Topic
clinical trials
WHO launches first clinical trials of antivirals for Bundibugyo Ebola
The World Health Organization has initiated randomized controlled trials for antiviral treatments and post-exposure prophylaxis to combat a deadly Bundibugyo Ebola outbreak in the DRC.
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
With no licensed vaccines for the rare Bundibugyo strain of Ebola, researchers are testing repurposed antiviral drugs and monoclonal antibodies in the DRC.
Residents in Congo cling to hope as Ebola treatment trial begins
Researchers have launched a study in eastern Congo to determine if remdesivir, MBP134, or a combination of both can increase survival rates for those infected with the Bundibugyo virus.
Trial for Bundibugyo Ebola treatment starts in DRC, WHO says
A new clinical trial has enrolled its first patient in the Democratic Republic of Congo, evaluating two priority therapies to combat the Bundibugyo Ebola outbreak.